FDA Adverse Event Malfunction Summary report: N

UNICEL® DXI 800 ACCESS® IMMUNOASSAY SYSTEM

MDR report key: 2092666 · Received May 18, 2011

Report

Report Number
2122870-2011-01392
Event Type
Malfunction
Date Received
May 18, 2011
Date of Event
April 18, 2011
Report Date
April 18, 2011
Manufacturer
BECKMAN COULTER INC.
Product Code
JJE
PMA / PMN Number
K023764
Removal / Correction Number
Z-0607-2011
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

BCI CUSTOMER SUPPORT HOTLINE FOUND THAT THE CUSTOMER'S FT3 REAGENT PACK WAS SHARED BETWEEN THE CUSTOMER'S TWO DXI 800 SYSTEMS. WHEN THE PACK IS SHARED, THE INSTRUMENT DOES NOT DETECT THAT THE PACK TEST COUNT IS INCORRECT. A PRODUCT CORRECTIVE ACTION LETTER PER BCI (B)(4) WAS DISTRIBUTED (B)(4) 2010 TO ALL NACO ACCESS AND UNICEL DXI CUSTOMERS. THE LETTER WARNS THAT ERRONEOUS RESULTS CAN BE PRODUCED IF REAGENT PACKS ARE NOT LOADED PROPERLY. INCLUDED IN THE DISTRIBUTION IS A WARNING LABEL FOR THE CUSTOMER TO AFFIX TO THE REAGENT PACK LOADING AREA OF THEIR SYSTEMS AND A LAMINATED REAGENT PACK LOADING GUIDE TO KEEP NEAR THEIR INSTRUMENT. THE CUSTOMER DISCARDED THE REAGENT PACK AND CONFIRMED THE PACK LOAD WARNING LABELS INCLUDED IN THE (B)(4) MAILING WERE APPROPRIATELY FIXED ONTO BOTH INSTRUMENTS. ROOT CAUSE IS ASSOCIATED WITH USER ERROR.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) TO REPORT THAT THE UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM GENERATED A MESSAGE OF REAGENT PACK MONITORING FAILURE IN THE EVENT LOG. THERE WERE NO PATIENT SAMPLES ANALYZED ON THE SHARED REAGENT PACK DURING THE EVENT. THE CUSTOMER DID NOT RECEIVE ANY REPORT OF PATIENT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED OR CONNECTED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL® DXI 800 ACCESS® IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER JJE BECKMAN COULTER INC. DXI 800 NA

Patients

Seq Age Sex Outcome Treatment
1